Signal: Roche to buy ulcerative colitis drug from Roivant for $7.1bn
Less than a year after Roivant purchased the IBD drug from Pfizer, it is selling it on for massive profit.
Drug Development In NASH
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
